Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recovery of resistant enterococci during vancomycin prophylaxis.

Literature DB >> 3384933

Recovery of resistant enterococci during vancomycin prophylaxis.

Abstract

We report a case of a patient undergoing hemodialysis who developed a wound infection and subsequently bacteremia with a strain of vancomycin-resistant enterococcus identified as Enterococcus gallinarum. He had been receiving vancomycin prophylaxis before developing these infections. Both isolates were susceptible to ampicillin, rifampin, teicoplanin, and daptomycin (LY146032).

Entities: Chemical Disease Species

Mesh：

Substances：
Vancomycin

Year: 1988 PMID： 3384933 PMCID： PMC266565 DOI： 10.1128/jcm.26.6.1216-1218.1988

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

13 in total

1. In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.

Authors: G M Eliopoulos; S Willey; E Reiszner; P G Spitzer; G Caputo; R C Moellering
Journal: Antimicrob Agents Chemother Date: 1986-10 Impact factor: 5.191

2. Evaluation of teicoplanin and vancomycin disk susceptibility tests.

Authors: A L Barry; C Thornsberry; R N Jones
Journal: J Clin Microbiol Date: 1986-01 Impact factor: 5.948

3. Emergence of vancomycin resistance in coagulase-negative staphylococci.

Authors: R S Schwalbe; J T Stapleton; P H Gilligan
Journal: N Engl J Med Date: 1987-04-09 Impact factor: 91.245

4. Vancomycin-resistant enterococci.

Authors: A H Uttley; C H Collins; J Naidoo; R C George
Journal: Lancet Date: 1988 Jan 2-9 Impact factor: 79.321

5. Drug resistance plasmids in Lactobacillus acidophilus and Lactobacillus reuteri.

Authors: M Vescovo; L Morelli; V Bottazzi
Journal: Appl Environ Microbiol Date: 1982-01 Impact factor: 4.792

6. Susceptibilities of enterococci to twelve antibiotics.

Authors: R W Tofte; J A Solliday; K B Crossley
Journal: Antimicrob Agents Chemother Date: 1984-04 Impact factor: 5.191

7. Lactobacillemia--report of nine cases. Important clinical and therapeutic considerations.

Authors: A S Bayer; A W Chow; D Betts; L B Guze
Journal: Am J Med Date: 1978-05 Impact factor: 4.965

8. Clinical and microbiologic aspects of serious infections caused by Staphylococcus epidermidis.

Authors: C U Tuazon; H Miller
Journal: Scand J Infect Dis Date: 1983

9. Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility.

Authors: D Kaye
Journal: Arch Intern Med Date: 1982-10-25

10. Common occurrence of plasmid DNA and vancomycin resistance in Leuconostoc spp.

Authors: P K Orberg; W E Sandine
Journal: Appl Environ Microbiol Date: 1984-12 Impact factor: 4.792

53 in total

1. Enterococcus gallinarum endocarditis occurring on native heart valves.

Authors: Sylvie Dargere; Michel Vergnaud; Renaud Verdon; Eric Saloux; Olivier Le Page; Roland Leclercq; Claude Bazin
Journal: J Clin Microbiol Date: 2002-06 Impact factor: 5.948

2. Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France.

Authors: K Gambarotto; M C Ploy; P Turlure; C Grélaud; C Martin; D Bordessoule; F Denis
Journal: J Clin Microbiol Date: 2000-02 Impact factor: 5.948

10. Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants.

Authors: Y K Siu; P C Ng; S C Fung; C H Lee; M Y Wong; T F Fok; K W So; K L Cheung; W Wong; A F Cheng
Journal: Arch Dis Child Fetal Neonatal Ed Date: 1998-09 Impact factor: 5.747

Recovery of resistant enterococci during vancomycin prophylaxis.

1. In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.

2. Evaluation of teicoplanin and vancomycin disk susceptibility tests.

3. Emergence of vancomycin resistance in coagulase-negative staphylococci.

4. Vancomycin-resistant enterococci.

5. Drug resistance plasmids in Lactobacillus acidophilus and Lactobacillus reuteri.

6. Susceptibilities of enterococci to twelve antibiotics.

7. Lactobacillemia--report of nine cases. Important clinical and therapeutic considerations.

8. Clinical and microbiologic aspects of serious infections caused by Staphylococcus epidermidis.

9. Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility.

10. Common occurrence of plasmid DNA and vancomycin resistance in Leuconostoc spp.

1. Enterococcus gallinarum endocarditis occurring on native heart valves.

2. Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France.

3. In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.

Review 4. Resistance of enterococci to glycopeptides.

Review 5. Recent taxonomic changes in the genus Enterococcus.

6. The enterococci: an enigma and a continuing therapeutic challenge.

7. In vitro detection of enterococcal vancomycin resistance.

8. Identification of Enterococcus species isolated from human infections by a conventional test scheme.

9. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.

10. Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants.